HUYABIO International today announced favorable Phase 1 clinical data for HBI-3000, a novel bioinspired investigational drug with promising antiarrhythmic properties, excellent tolerability and a ...

Atrial fibrillation (AF or afib) is a type of heart rhythm disorder, or arrhythmia. It causes your heart to beat irregularly and can significantly increase the heart rate, leading to your heart’s ...

Atrial fibrillation (AF or afib) involves abnormal electrical activity in the upper chambers (atria) of your heart, which causes the organ to beat quickly and irregularly. This abnormal beating ...

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

Biomarkers might improve risk stratification for patients with chronic kidney disease (CKD) at cardiovascular risk.

Valvular atrial fibrillation (A-fib) involves a condition that leads to an irregular or abnormal heart rhythm. This can increase a person’s risk of cardiovascular complications, such as stroke.

Restarting oral anticoagulants after spontaneous intracerebral haemorrhage reduces the risk for ischaemic stroke but ...

Depending on how the heart’s electrical activity appears on an EKG, a doctor may diagnose coarse or fine ventricular fibrillation (VF). Coarse VF appears as larger waves on an EKG compared with the ...

Atrial fibrillation diagnosed before age 70 years is associated with a 21% increased risk of developing dementia and a 36% higher risk for early-onset forms of the condition, according to the results ...

In the DECAF (Does Eliminating Coffee Avoid Fibrillation) trial, the researchers found that caffeine resulted in a 39% lower risk of recurrent AF events, compared to those who abstained – and they ...